Trending >

ADVERTISE WITH CANTECH

contributor

Staff

The Latest From Staff

American Tech lyv

Take a pass on Live Nation, this investor says

American Tech Analysts META

Meta Platforms is a Buy, says Roth Capital

Analysts eCommerce amzn

Amazon has upside from here, says Roth Capital

Analysts eCommerce shop

Buy Shopify on the dip, says National Bank

Analysts Resource Tech aqn

Algonquin Power is one of my Top Picks, this investor says

Analysts mtlo

Martello Technologies is heading higher, says Paradigm

Analysts IT cts

Converge Technology Solutions keeps Buy rating with Eight Capital

Analysts Health qipt

Quipt Home Medical has a 79 per cent upside, says Raymond James

Analysts acgl

Arch Capital gets a target raise from Roth

Analysts Marketing tixt

TELUS International gets target trimmed by National Bank

Analysts Pharma and Biotech acog

Alpha Cognition gets rating downgrade from Raymond James

American Tech Analysts uber

Uber Technologies is a Buy, says Roth

Analysts Gaming ttwo

Take-Two has target cut by Roth Capital

Analysts Cannabis db

Decibel Cannabis is heading higher, says Haywood

Analysts eCommerce mdf

MDF Commerce’s profitability looks better, says Laurentian

American Tech Analysts amzn

Amazon is a Buy, says Roth Capital

Analysts Software otex

OpenText has an 83 per cent upside, says National Bank

Analysts eCommerce lspd

Lightspeed Commerce is still undervalued, says ATB

Telco bce

BCE Inc is a clear Buy at these levels, this investor says

Analysts Gaming ea

Take a pass on Electronic Arts, says Roth

Analysts QTRH

Quarterhill is good for a double, this investor says

Analysts einc

E Inc has a 165 per cent upside, says ATB

Analysts Cannabis mrmd

MariMed has a 167 per cent upside, says Echelon

Analysts Software real

Real Matters keeps Outperform rating with ATB

Airlines ac

We’re buying Air Canada stock, this portfolio manager says

American Tech amzn

Three reasons why you’ll want to own Amazon in 2023

Analysts Health care

iA Capital stays bullish on Dialogue Health Technologies

dis

Disney is good for a double, this investor says

Analysts Pharma and Biotech eprx

Eupraxia is heading to $9 per share, says Raymond James

Analysts

Technicals add to bull case for the market, says Paradigm

Share

Tweet

Share

Get Stock Picks from the Pros. In your Inbox.